T. Arslan et al. / Tetrahedron 66 (2010) 2936–2939
2939
crystals, mp 232–233 ꢁC): 1H NMR (400 MHz, DMSO-d6):
d
11.61 (br
2H). 13C NMR (100 MHz, DMSO-d6):
d
199.1, 152.5, 152.0, 149.9,
s, NH, 1H), 7.42 (d, J¼7.9 Hz, ]CH, 1H), 7.22 (t, J¼7.9 Hz, ]CH, 1H),
6.91 (t, J¼7.9 Hz, ]CH, 1H), 6.73 (d, J¼7.9 Hz, ]CH, 1H), 6.58 (s,
]CH, 1H), 3.16–3.14 (m, CH2, 2H), 2.46–2.44 (m, CH2, 2H). 13C NMR
135.8,133.9,132.5,129.6,128.8,127.1,125.6,125.4,125.2,121.5,119.1,
113.0, 112.4, 37.6, 26.5, 22.9. IR (KBr, cmꢂ1) 3338, 2918, 2857, 1776,
1700, 1619, 1577, 1488, 1412, 1258, 1127. Anal. Calcd for C22H18N4O3:
C, 68.38; H, 4.70; N, 14.50. Found: C, 68.63; H, 4.68; N, 14.56.
(100 MHz, DMSO-d6): d 208.3, 163.4, 157.2, 147.2, 137.3, 135.7, 132.7,
130.9, 126.3, 125.7, 121.2, 118.0, 114.6, 113.4, 112.8, 106.8, 102.5, 34.9,
29.3. IR (KBr, cmꢂ1) 3288, 2924, 2224, 1650, 1586, 1446. Anal. Calcd
for C21H10ClN3O3: C, 65.04; H, 2.60; N, 10.84. Found: C, 64.93; H,
2.89; N, 11.03.
Acknowledgements
We are greatly indebted to The Scientific and Technical Research
Council of Turkey (TUBITAK, Grant No. TBAG-107T073) for their
financial support for this work.
4.1.10. 4-Chloro-3,6-dioxo-5-(2-(3-oxocyclohex-1-enyl)-1H-indol-3-
yl)cyclohexa-1,4-diene-1,2-dicarbonitrile (34). The Michael adduct
34 was prepared as described for 33. For 34 (140 mg, 74%, orange
crystals from acetone, mp 230–232 ꢁC): 1H NMR (400 MHz, DMSO-
Supplementary data
d6):
d
11.54 (br s, NH, 1H), 7.39 (d, J¼7.8 Hz, ]CH, 1H), 7.17 (t,
Supplementary data associated with this article can be found in
J¼7.8 Hz, ]CH, 1H), 6.88 (t, J¼7.8 Hz, ]CH, 1H), 6.68 (d, J¼7.8 Hz,
]CH, 1H), 6.57 (s, ]CH, 1H), 2.92 (t, J¼5.7 Hz, CH2, 2H), 2.38 (t,
J¼6.6 Hz, CH2, 2H), 2.08–2.01 (m, CH2, 2H). 13C NMR (100 MHz,
References and notes
DMSO-d6):
d 198.9, 156.8, 150.0, 147.6, 136.5, 135.1, 132.6, 130.8,
1. Pindur, U. In Advances in nitogen Heterocycles; Moddy, C. J., Ed.; JAI: Greenwich,
1995; Vol. 1, pp 121–172.
125.1, 123.7, 123.3, 121.0, 118.5, 117.6, 114.5, 113.2, 112.7, 106.5, 102.8,
37.6, 27.0, 22.8. IR (KBr, cmꢂ1) 3355, 2935, 2229, 1711, 1619, 1583,
1412, 1356, 1239. Anal. Calcd for C22H12ClN3O3: C, 65.76; H, 3.01; N,
10.46. Found: C, 65.90; H, 3.07; N, 10.38.
2. Joule, J. A. Adv. Hetrocycl. Chem. 1984, 35, 83–198.
3. Pfeuffer, L.; Pindur, U. Helv. Chim. Acta 1987, 70, 1419–1428.
4. Eitel, M.; Pindur, U. J. Org. Chem. 1990, 55, 5368–5374.
5. Noland, W. E.; Xia, G.-M.; Gee, K. R.; Konkel, M. J.; Wahlstrom, M. J.; Condoluci,
J. J.; Rieger, D. L. Tetrahedron 1996, 52, 4555–4572.
4.1.11. (E)-4-Chloro-3,6-dioxo-5-(2-(3-oxocyclooct-1-enyl)-1H-indol-
3-yl)cyclohexa-1,4-diene-1,2-dicarbonitrile (35). The vinylindole 35
was prepared as described for 33. For 35 (60 mg, 33%, yellow
crystals from acetone, mp 185–186 ꢁC): 1H NMR (400 MHz, DMSO-
6. Beccalli, E. M.; Marchesini, A. Tetrahedron 1996, 52, 3029–3036.
7. Dufour, B.; Motorina, I.; Fowler, F. W.; Grierson, D. S. Heterocycles 1994, 37,
1455–1458.
8. Pindur, U. Heterocycles 1988, 27, 1253–1268.
´
´
9. Joseph, B.; Da Costa, H.; Merour, J.-Y.; Leonce, S. Tetrahedron 2000, 56, 3189–
3196.
d6):
d
11.38 (m, NH, 1H), 7.36 (dd, J¼7.2 Hz, 1.0 Hz, ]CH, 1H), 7.15
10. Rodriguez-Salvador, L.; Zaballos-Garcia, E.; Gonzalez-Rosende, E.; Djebouri Sidi,
M.; Sepulveda-Arques, J.; Jones, R. A. Synth. Commun. 1997, 27, 1439–1447.
11. Balasubramanian, T.; Balasubramanian, K. K. Chem. Commun. 1994, 1237–1238.
12. Macor, J. E. Heterocycles 1990, 31, 993–998.
13. Madalengoitia, J. S.; Macdonald, T. L. Tetrahedron Lett. 1993, 34, 6237–6240.
14. Blechert, S.; Wirth, T. Tetrahedron Lett. 1992, 33, 6621–6624.
15. Wiest, O.; Steckhan, E. Angew. Chem., Int. Ed. Engl. 1993, 32, 901–903.
16. Elango, S.; Srinivasan, P. C. Tetrahedron Lett. 1993, 34, 1347–1350.
17. Padwa, A.; Lynch, S. M.; Mejia-Oneto, J. M.; Zhang, H. J. Org. Chem. 2005, 70,
2206–2218.
(td, J¼7.2, 1.0 Hz, ]CH, 1H), 6.88 (td, J¼7.2, 1.0 Hz, ]CH,1H), 6.71 (s,
]CH, 1H), 6.67 (d, J¼7.2 Hz, ]CH, 1H), 3.22 (t, J¼6.6 Hz, CH2, 2H),
2.82 (t, J¼7.2 Hz, CH2, 2H), 1.74–1.69 (m, CH2, 4H), 1.53–1.52 (m,
CH2, 2H). 13C NMR (100 MHz, DMSO-d6):
d 202.5, 157.4, 147.0, 142.6,
135.6, 134.5, 132.3, 131.11, 131.1, 125.5, 124.6, 120.8, 118.8, 117.3,
114.9, 113.1, 112.8, 105.9, 102.2, 43.0, 28.9, 24.5, 23.7, 23.5. IR (KBr,
cmꢂ1) 3338, 2941, 2302, 2235, 1622, 1580, 1530, 1415, 1348, 1328,
1269, 1239, 1194, 1169. Anal. Calcd for C24H16ClN3O3: C, 67.06; H,
3.75; N, 9.78. Found: C, 67.31; H, 3.62; N, 10.01.
18. Rosillo, M.; Dominguez, G.; Casarrubios, L.; Amador, U.; Perez-Castells, J. J. Org.
Chem. 2004, 69, 2084–2093.
19. Pfeuffer, L.; Pindur, U. Helv. Chim. Acta 1988, 71, 467–471.
20. Conchon, E.; Anizon, F.; Aboab, B.; Prudhomme, M. J. Med. Chem. 2007, 50,
4669–4680.
21. Sadak, A. E.; Arslan, T.; Celebioglu, N.; Saracoglu, N. Tetrahedron, in press.
4.1.12. 1-(2-(3-Oxocyclopent-1-enyl)-1H-indol-3-yl)-4-phenyl-1,2,4-
triazolidine-3,5-dione (36). A solution of 15 (160 mg, 0.81 mmol)
and PTAD (142 mg, 0.81 mmol) in CH2Cl2 (20 mL) was stirred
magnetically at room temperature for 24 h. After CH2Cl2 was
evaporated, acetone (15 mL) was added to the reaction mixture.
The solution with acetone was decanted and the precipitate was
filtered and dried to give 36 (135 mg, 45%, pale yellow crystals, mp
22. Scopes, D. I. C.; Allen, M. S.; Hignett, G. J.; Wilson, N. D. V.; Harris, M.; Joule, J. A.
J. Chem. Soc., Perkin Trans. 1 1977, 2376–2385.
23. Çavdar, H.; Saraçog˘lu, N. Tetrahedron 2005, 61, 2401–2405.
24. Cavdar, H.; Saracoglu, N. J. Org. Chem. 2006, 71, 7793–7799.
25. Lewandowska, E. Tetrahedron 2006, 63, 2107–2122.
26. Saracoglu, N. Top. Heterocycl. Chem. 2007, 11, 1–61.
27. Agnusdei, M.; Bandini, M.; Melloni, A.; Umani-Ronchi, A. J. Org. Chem. 2003, 68,
7126–7719.
28. Harrington, P.; Kerr, M. A. Synlett 1996, 1047–1050.
29. Harrington, P.; Kerr, M. A. Can. J. Chem. 1998, 76, 1256–1265.
30. Yadav, J. S.; Abraham, S.; Reddy, B. V. S.; Sabitha, G. Synthesis 2001, 2165–2169.
31. Bandini, M.; Melchiorre, P.; Melloni, A.; Umani-Ronchi, A. Synthesis 2002, 1110–
1114.
32. Bandini, M.; Fagioli, M.; Melloni, A.; Umani-Ronchi, A. Synthesis 2003, 397–402.
33. Yadav, J. S.; Reddy, B. V. S.; Swamy, T. Synthesis 2004, 106–110.
34. Alam, M. M.; Varala, R.; Adapa, S. R. Tetrahedron Lett. 2003, 44, 5115–5119.
35. Hong, L.; Liu, C.; Sun, W.; Wang, L.; Wong, K.; Wang, R. Org. Lett. 2009, 11, 2177–
2180.
285–286 ꢁC): 1H NMR (400 MHz, DMSO-d6):
d 12.15 (m, NH, 1H),
11.46 (m, NH, 1H), 7.61–7.50 (m, ]CH, 6H), 7.43 (br t, J¼7.3 Hz,
]CH, 1H), 7.33 (br t, J¼7.3 Hz, ]CH, 1H), 7.16 (br t, J¼7.3 Hz, ]CH,
1H), 6.72 (d, J¼1.5 Hz, ]CH, 1H), 3.28–3.15 (m, CH2, 2H), 2.50–2.48
(m, CH2, 2H). 13C NMR (100 MHz, DMSO-d6):
d 208.9, 163.5, 152.0,
146.1, 136.4, 130.6, 130.3, 130.2, 129.5, 128.3, 127.5, 126.9, 125.7,
125.2 121.5, 119.7, 113.1, 35.1, 28.6. IR (KBr, cmꢂ1) 3225, 2901, 2847,
1752, 1603, 1558, 1468, 1392, 1258, 1048, 987. Anal. Calcd for
C21H16N4O3: C, 67.73; H, 4.33; N, 15.05. Found: C, 67.95; H, 4.30; N,
14.93.
36. Blay, G.; Ferna´ndez, I.; Monleo´ n, A.; Pedro, J. R.; Vila, C. Org. Lett. 2009, 11,
441–444.
37. Zeng, M.; Kang, Q.; He, Q.-L.; You, S.-L. Adv. Synth. Catal. 2008, 350,
2169–2173.
38. Kang, Q.; Zheng, X.-J.; You, S.-L. Chem.dEur. J. 2008, 14, 3539–3542.
39. Blay, G.; Fernandez, I.; Pedro, J. R.; Vila, C. Tetrahedron Lett. 2007, 48, 6731–6734.
40. Evans, D. A.; Fandrick, K. R.; Song, H.-J.; Scheidt, K. A.; Xu, R. J. Am. Chem. Soc.
2007, 129, 10029–10041.
41. Takenaka, N.; Sarangthem, R. S.; Seerla, S. K. Org. Lett. 2007, 9, 2819–2822.
42. Evans, D. A.; Fandrick, K. R. Org. Lett. 2006, 8, 2249–2252.
43. Cho, S. H.; Chang, S. Angew. Chem., Int. Ed. 2008, 47, 2836–2839.
4.1.13. 1-(2-(3-Oxocyclohex-1-enyl)-1H-indol-3-yl)-4-phenyl-1,2,4-
triazolidine-3,5-dione (37). The Michael adduct 37 was prepared as
described for 36. For 37 (90 mg, 50%, pale yellow crystals from ac-
etone, mp 225–226 ꢁC): 1H NMR (400 MHz, DMSO-d6):
d 11.95 (m,
NH, 1H), 7.56–7.41 (m, ]CH, 7H), 7.28 (dd, J¼8.2, 7.2 Hz, ]CH, 1H),
7.12 (t, J¼7.2 Hz, ]CH, 1H), 6.51 (d, J¼0.8 Hz, ]CH, 1H), 2.87 (t,
J¼5.7 Hz, CH2, 2H), 2.41 (t, J¼6.4 Hz, CH2, 2H), 2.07–2.06 (m, CH2,